Physician

Christopher W. Deitch, MD

According to 2025 Medicare claims, Christopher Deitch, MD (NPI: 1528154903) practices gastroenterology in the Wilmington, DE-MD-NJ market, with the plurality of this provider's patient population coming from Salem, NJ. This provider's primary affiliated billing organization is CMC DEPT OF MEDICINE GROUP PA (NPI: 1386682094; TIN: 223266219) and primary practice location at 08054-3419.

Deitch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 471 traditional Medicare patients, billed 760 HCPCS/CPT codes, and received $81,226 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,034 prescription claims across 303 beneficiaries totaling $441,816 in drug costs, led by Xifaxan (Rifaximin). DME data shows 23 claims. Open Payments data shows 23 records totaling $797. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $126,485 to $81,226. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,637,886 to $441,816. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	656	1,086	$126,485
2016	597	1,006	$111,214
2017	579	1,025	$110,428
2018	567	1,090	$117,190
2019	496	872	$94,677
2020	383	667	$68,176
2021	467	842	$95,977
2022	488	822	$90,795
2023	485	783	$86,011
2024	471	760	$81,226

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	367	1,048	$1,637,886
2016	344	1,117	$1,594,890
2017	375	1,231	$724,891
2018	369	1,218	$769,513
2019	411	1,348	$955,065
2020	334	1,217	$574,502
2021	207	1,027	$287,732
2022	278	914	$192,498
2023	342	977	$388,064
2024	303	1,034	$441,816

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$914
2016	N/R	23	$1,488
2017	N/R	24	$1,611
2018	N/R	48	$3,426
2019	N/R	11	$936
2020	N/R	24	$2,125
2021	N/R	24	$2,151
2022	N/R	24	$2,210
2023	N/R	N/R	N/R
2024	N/R	23	$2,790

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	79	81	$218
45380	Biopsy of large bowel using a flexible endoscope	62	63	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	100	121	$100
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	79	81	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	145	170	$67

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xifaxan	Rifaximin	18	509	$50,324
Creon	Lipase/Protease/Amylase	13	619	$40,686
Linzess	Linaclotide	50	1,620	$29,185
Octreotide Acetate	Octreotide Acetate	12	360	$9,725
Peg 3350-Electrolyte	Sodium Chloride/Nahco3/Kcl/Peg	116	162	$2,484

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4150	Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	12	$1,510
B4036	Enteral feeding supply kit; gravity fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	11	$1,280

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$797	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher W. Deitch, MD?

Tedicare shows public-source Medicare data for Christopher W. Deitch, MD (NPI 1528154903), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher W. Deitch, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher W. Deitch, MD?

Christopher W. Deitch, MD is linked to CMC DEPT OF MEDICINE GROUP PA (billing NPI 1386682094) in the available physician profile data.

Does Christopher W. Deitch, MD have Open Payments data?

Christopher W. Deitch, MD has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.